Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
Promising findings have been seen with PD-1 inhibitors in non-small cell lung cancer(NSCLC), Thomas E. Stinchcombe, MD, explains. In the phase II ...
Aduro Biotech, Inc. announced the initiation of an investigator-sponsored Phase 2 clinical trial of the company's immuno-oncology product candidates ...
Experts at the Institute of Cancer Research found that they can use an ... “But just as there are high hopes for immunotherapy as a future cancer ...
New breast cancer test links immune 'hotspots' to better survival - Medical Xpress
... cancer trial of its investigational cancer immunotherapy treatment Multikine* (Leukocyte Interleukin, Injection). Belarus is the 21th country to approve ...
The test, described today (Friday) in the journal Modern Pathology, could assess whether a woman's immune system is holding a cancer at bay - and ...
New test predicts a woman's chance of surviving breast cancer: Images track disease hotspots ... - Daily Mail
Platinum-based treatment could have dramatic response in some patients diagnosed with pancreatic cancer. Two patients who received this therapy ...
Researchers identify pancreatic cancer patients who benefit from personalized treatment - Medical Xpress
Like a stealth jet cloaks itself from radar, cancer cells cloak themselves within tumors by hiding behind a dense layer of cellular material known as ...
The Hyderabad-based Global Hospitals has performed an innovative medical procedure called Total Laparoscopic Whipples operation to treat ...
Researchers at the University of Birmingham believe that a simple urine test could help to guide clinicians in the treatment of bladder cancer patients.
Urine test could help to guide treatment of bladder cancer - Oncology Nurse Advisor
Patients that received chemotherapy after bladder cancer surgery demonstrated an approximately 30% lower risk of death than those that underwent ...
Bladder cancer constitutes the ninth most common cancer worldwide and approximately only 30% of cases are muscle invasive at initial diagnosis.
ORLANDO, FL, USA (UroToday.com) - Colin Dinney, MD presented work from his own laboratory at M.D. Anderson Cancer Center. His group's ...
Dr. Apolo then transitioned to a discussion about the use of immunotherapy in bladder cancer. Immune checkpoint targeting has resulted in significant ...
U.S. EPA estimates the 80 parts per billion standard prevents an estimated 280 cases of bladder cancer each year out of a total of more than 330 ...
In bladder cancer, the focus of personalized medicine should be targeted toward identification and treatment of those who are at risk for progression.
However, limited data exist regarding the prognostic significance of SIR in bladder cancer. We investigate the utility of pretreatment SIR in patients with ...
... In this study, the authors looked at asymptomatic versus symptomatic recurrences after radical cystectomy for muscle-invasive bladder cancer.
BACKGROUND: The optimal use of urine markers in the surveillance of non-muscle-invasive bladder cancer(NMIBC) remains unclear. Aim of the ...
Bill Williams beat brain cancer. 15 years after his diagnosis, and having celebrated his 70th birthday, he tells how he used cheap, common medicines to build his complementary and integrative programme. And he defied all the odds.
A minor revolution is occurring in cancer treatment and it concerns about 60 or so new cancer drugs. Or rather, old non-cancer drugs relaunched as cancer drugs. The official term is ‘Drug repurposing’. Let´s be clear. These drugs already exist, they have been around for years, doctors know exactly what they do, and exactly what the side effects are (usually slight). But we are talking current antacids and acne treatments.
Colorectal cancer - or gut bacteria problems?
Increasingly, the symptoms of colorectal appear more and more like the symptoms of a damaged microbiome. Here's a revised update.
Curcumin Cimetidine
B-17 - an 'alternative' cancer treatment'?
B-17 as a cancer ´cure´ is one of the most controversial subjects in ´Alternative cancer medicine´. Is there research to support it as an alternative cancer treatment? Is there research to support it as a complementary therapy? Is there research to support B-17 as a cure for cancer? Here we bring you one of the most comprehensive reviews on the Internet today.
New treatments for brain tumours
We have more than our fair share of people coming to us who have brain tumours, particularly glioblastomas. And there are several interesting developments of late which you should know about. I have updated the introduction on our website to include them, and have provided some links below. Start with the review..
Immunotherapy - the new frontier
The drugs companies are getting excited. But we aren't. We've been talking about it for twelve years - getting your immune system into shape so it can kill off the cancer.
ASCO GU Symposium February 27, 2015
High-Dose Radiotherapy Fails to Improve Prostate Cancer Survival
High-dose radiation therapy did not improve overall survival compared with the standard dose in stage II localized prostate cancer, but did show some benefits.
High-dose radiation therapy did not improve overall survival compared with the standard dose in stage II localized prostate cancer, but did show some benefits.
Increased Risk of Aggressive Prostate Cancer in Testicular Cancer Survivors
Patients with a history of testicular cancer had a fivefold higher risk of developing aggressive prostate cancer when compared with those with no history of testicular cancer.
Patients with a history of testicular cancer had a fivefold higher risk of developing aggressive prostate cancer when compared with those with no history of testicular cancer.
Surveillance Risky in Intermediate-Risk Prostate Cancer?
Intermediate-risk prostate cancer patients managed with active surveillance had worse outcomes compared with low-risk patients also managed with surveillance.
Intermediate-risk prostate cancer patients managed with active surveillance had worse outcomes compared with low-risk patients also managed with surveillance.
OncoTherapy Network
Slide Show: Prostate Cancer
This slide show features pathology slides and PET/CT scans of prostate cancer, as well as various images of bone lesions from metastatic disease.
This slide show features pathology slides and PET/CT scans of prostate cancer, as well as various images of bone lesions from metastatic disease.
Science Daily Cancer News
About 10 percent of patients with chronic lymphocytic leukemia discontinued therapy with the Bruton tyrosine kinase inhibitor drug ibrutinib because of disease progression during clinical trials, according to a new study.
In theory, a tumor is an army of clones, made up of many copies of the original cancerous cell. But tumor cells don't always act like duplicates, and their unpredictable behavior can create problems for treatment. For while some cells within a tumor succumb to anti-cancer drugs, others may survive to bring the cancer back to life once therapy has ended.
A surgical algorithm developed and implemented by ovarian cancer specialists dramatically increases the frequency of complete removal of all visible tumor – a milestone strongly tied to improved survival. The algorithm is a framework for a personalized surgical approach that allows surgeons to be "much smarter about whom we operate on up front, providing a more individualized approach to surgery that's led to better results for our patients," said one clinician.
A protein commonly found in human cells could be an important switch that activates cancer cell metastasis, according to a new study. The finding focuses attention on a biological mechanism that until now was largely overlooked. The discovery of the protein's effect significantly expands our understanding of epithelial cancers such as breast and lung cancer.
A new tool allows researchers to explore how alterations in more than 2,000 proteins affect the diverse biological functions in which these molecules are involved. The tool may help gain a more global view of the causes of tumor development.
Scientists have developed a new test that can predict the survival chances of women with breast cancer by analyzing images of 'hotspots' where there has been a fierce immune reaction to a tumor. Researchers used statistical software previously used in criminology studies of crime hotspots to track the extent to which the immune system was homing in and attacking breast cancer cells.
A simple urine test could help to guide clinicians in the treatment of bladder cancer patients, researchers believe. Being able to reliably identify those patients with the most aggressive cancers early via urine tests, and expediting aggressive therapeutic strategies, may significantly improve outcomes, they say.
Global health experts believe the current data on cancer prevalence, incidence and mortality in sub-Saharan Africa -- which determines how billions of pounds of international development money is spent -- are weak and could mean vital funds are being deflected from other priorities. These include diarrheal and waterborne diseases, malnutrition, sanitation and the need to strengthen health systems.
Scientists have a developed a new method to monitor the effect of anti-cancer drugs on very rare leukemia stem cells. The approach potentially allows doctors to screen patients and personalize their treatment.
Tambahkan Komentar